Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
ACA Quote, Financials, Valuation and Earnings
Last price:
$90.08
Seasonality move
:
6.95%
Day range:
$85.78 - $87.88
52-week range:
$68.11 - $113.43
Dividend yield:
0.23%
P/E ratio:
55.14x
P/S ratio:
1.65x
P/B ratio:
1.74x
Volume:
246.3K
Avg. volume:
262.7K
1-year change:
-5.54%
Market cap:
$4.3B
Revenue:
$2.6B
EPS (TTM):
$1.59
Earnings Data
Next earnings date for ACA
Aug 01
2025
Most recent earnings per share
$0.48
Beat by $0.30
(May 6/2025)
Consensus Estimate
$0.18
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $776M | -- | -- | $1.30 | -- |
| 08/01/2025 | Q2 | $757.8M | -- | -- | $1.09 | -- |
| 05/06/2025 | Q1 | $614.5M | $632M | $0.48 | $0.18 | $0.30 |
| 02/27/2025 | Q4 | $690.3M | $666.2M | -$0.16 | $0.76 | -$0.92 |
| 10/30/2024 | Q3 | $685M | $640.4M | $0.34 | $0.85 | -$0.51 |
| 08/01/2024 | Q2 | $661.5M | $664.7M | $0.93 | $0.83 | $0.10 |
| 05/02/2024 | Q1 | $580.1M | $598.6M | $0.80 | $0.52 | $0.28 |
| 02/22/2024 | Q4 | $554.5M | $582.2M | $0.56 | $0.49 | $0.07 |
| 11/01/2023 | Q3 | -- | -- | $0.72 | $0.68 | $0.04 |
| 08/03/2023 | Q2 | -- | -- | $0.84 | $0.59 | $0.25 |
| 04/27/2023 | Q1 | -- | -- | $1.14 | $0.54 | $0.60 |
| 02/23/2023 | Q4 | -- | -- | $3.18 | $0.21 | $2.98 |
| 11/02/2022 | Q3 | -- | -- | $0.66 | $0.63 | $0.03 |
| 08/03/2022 | Q2 | -- | -- | $0.79 | $0.46 | $0.33 |
| 04/28/2022 | Q1 | -- | -- | $0.41 | $0.22 | $0.19 |
| 02/23/2022 | Q4 | -- | -- | $0.19 | $0.21 | -$0.02 |
| 11/04/2021 | Q3 | -- | -- | $0.49 | $0.50 | -$0.01 |
| 08/05/2021 | Q2 | -- | -- | $0.43 | $0.57 | -$0.14 |
| 04/29/2021 | Q1 | -- | -- | $0.32 | $0.21 | $0.11 |
| 02/24/2021 | Q4 | -- | -- | $0.21 | -- | -- |
| 10/28/2020 | Q3 | -- | -- | $0.64 | -- | -- |
| 07/30/2020 | Q2 | -- | -- | $0.68 | -- | -- |
| 04/28/2020 | Q1 | -- | -- | $0.65 | -- | -- |
| 02/26/2020 | Q4 | -- | -- | $0.43 | -- | -- |
| 10/30/2019 | Q3 | -- | -- | $0.67 | -- | -- |
| 08/01/2019 | Q2 | -- | -- | $0.65 | -- | -- |
| 05/02/2019 | Q1 | -- | -- | $0.56 | -- | -- |
| 02/27/2019 | Q4 | -- | -- | $0.56 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.07 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.46 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.45 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.48 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.42 | -- | -- |
Arcosa Earnings Questions
-
How Much did Arcosa Generate in Revenue Last Quarter?
Arcosa reported $632M worth of top line sales in its most recent quarter.
-
Did Arcosa Beat Earnings Last Quarter?
Arcosa announced earnings per share of $0.48 which represents a beat of analyst forecast a $0.18 per share.
-
Is Arcosa Profitable?
Arcosa reported $125.4M that represents $2.55 per share over the last quarter.
-
What is the Analyst Consensus for Arcosa EPS Next Year?
Arcosa's earnings are forecast to grow from $1.91 per share to $3.26 per share next year representing an increase of 97.28%.
-
When is Arcosa's Earnings Date?
Arcosa's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
